메뉴 건너뛰기




Volumn 13, Issue 4, 2009, Pages 304-310

Is an HIV vaccine possible?

Author keywords

Challenges; HIV; Vaccine

Indexed keywords

ENVELOPE PROTEIN; GAG PROTEIN; GLYCAN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; LIVE VACCINE; NEF PROTEIN; NEUTRALIZING ANTIBODY; POL PROTEIN; VIRUS VECTOR;

EID: 77949833920     PISSN: 14138670     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1413-86702009000400013     Document Type: Review
Times cited : (14)

References (46)
  • 1
    • 0033952103 scopus 로고    scopus 로고
    • Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection
    • Baba T.W., Liska V., Hofmann-Lehmann R. et al. Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian-human immunodeficiency virus infection. Nat Med 2000; 6:200-206.
    • (2000) Nat Med , vol.6 , pp. 200-206
    • Baba, T.W.1    Liska, V.2    Hofmann-Lehmann, R.3
  • 2
    • 0033951746 scopus 로고    scopus 로고
    • Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies
    • Mascola J.R., Stiegler G., VanCott T.C. et al. Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodies. Nat Med 2000; 6:207-210.
    • (2000) Nat Med , vol.6 , pp. 207-210
    • Mascola, J.R.1    Stiegler, G.2    VanCott, T.C.3
  • 3
    • 0034864776 scopus 로고    scopus 로고
    • Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/ human immunodeficiency virus at serum levels giving complete neutralization in vitro
    • Parren P.W., Marx P.A., Hessell A.J. et al. Antibody protects macaques against vaginal challenge with a pathogenic R5 simian/ human immunodeficiency virus at serum levels giving complete neutralization in vitro. J Virol 2001; 75:8340-8347.
    • (2001) J Virol , vol.75 , pp. 8340-8347
    • Parren, P.W.1    Marx, P.A.2    Hessell, A.J.3
  • 4
    • 0036786482 scopus 로고    scopus 로고
    • Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection
    • Allen T.M., Jing P., Calore B. et al. Effects of cytotoxic T lymphocytes (CTL) directed against a single simian immunodeficiency virus (SIV) Gag CTL epitope on the course of SIVmac239 infection. J Virol 2002; 76:10507-10511.
    • (2002) J Virol , vol.76 , pp. 10507-10511
    • Allen, T.M.1    Jing, P.2    Calore, B.3
  • 5
    • 0036194524 scopus 로고    scopus 로고
    • Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication
    • Allen T.M., Mortara L., Mothe B.R. et al. Tat-vaccinated macaques do not control simian immunodeficiency virus SIVmac239 replication. J Virol 2002; 76:4108-4112.
    • (2002) J Virol , vol.76 , pp. 4108-4112
    • Allen, T.M.1    Mortara, L.2    Mothe, B.R.3
  • 6
    • 10744225749 scopus 로고    scopus 로고
    • Multispecific vaccineinduced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239
    • Vogel T.U., Reynolds M.R., Fuller D.H. et al. Multispecific vaccineinduced mucosal cytotoxic T lymphocytes reduce acute-phase viral replication but fail in long-term control of simian immunodeficiency virus SIVmac239. J Virol 2003; 77:13348-13360.
    • (2003) J Virol , vol.77 , pp. 13348-13360
    • Vogel, T.U.1    Reynolds, M.R.2    Fuller, D.H.3
  • 7
    • 0035668020 scopus 로고    scopus 로고
    • Non-human primates: Essential partners in biomedical research
    • Bontrop R.E. Non-human primates: essential partners in biomedical research. Immunol Rev 2001; 183:5-9.
    • (2001) Immunol Rev , vol.183 , pp. 5-9
    • Bontrop, R.E.1
  • 8
    • 1842328057 scopus 로고    scopus 로고
    • Simian immunodeficiency virus variants with differential T-cell and macrophage tropism use CCR5 and an unidentified cofactor expressed in CEMx174 cells for efficient entry
    • Kirchhoff F., Pohlmann S., Hamacher M. et al. Simian immunodeficiency virus variants with differential T-cell and macrophage tropism use CCR5 and an unidentified cofactor expressed in CEMx174 cells for efficient entry. J Virol 1997; 71:6509-6516.
    • (1997) J Virol , vol.71 , pp. 6509-6516
    • Kirchhoff, F.1    Pohlmann, S.2    Hamacher, M.3
  • 9
    • 0030892146 scopus 로고    scopus 로고
    • Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry
    • Chen Z., Zhou P., Ho D.D., Landau N.R., and Marx P.A. Genetically divergent strains of simian immunodeficiency virus use CCR5 as a coreceptor for entry. J Virol 1997; 71:2705-2714.
    • (1997) J Virol , vol.71 , pp. 2705-2714
    • Chen, Z.1    Zhou, P.2    Ho, D.D.3    Landau, N.R.4    Marx, P.A.5
  • 10
    • 0032551184 scopus 로고    scopus 로고
    • Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: A comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac
    • Chen Z., Gettie A., Ho D.D., and Marx P.A. Primary SIVsm isolates use the CCR5 coreceptor from sooty mangabeys naturally infected in west Africa: a comparison of coreceptor usage of primary SIVsm, HIV-2, and SIVmac. Virology 1998; 246:113-124.
    • (1998) Virology , vol.246 , pp. 113-124
    • Chen, Z.1    Gettie, A.2    Ho, D.D.3    Marx, P.A.4
  • 11
    • 17844374605 scopus 로고    scopus 로고
    • Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection
    • Mattapallil J.J., Douek D.C., Hill B. et al. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 2005; 434:1093-1097.
    • (2005) Nature , vol.434 , pp. 1093-1097
    • Mattapallil, J.J.1    Douek, D.C.2    Hill, B.3
  • 12
    • 17844376742 scopus 로고    scopus 로고
    • Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells
    • Li Q., Duan L., Estes J.D. et al. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 2005; 434:1148-1152.
    • (2005) Nature , vol.434 , pp. 1148-1152
    • Li, Q.1    Duan, L.2    Estes, J.D.3
  • 13
    • 29244455769 scopus 로고    scopus 로고
    • Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag
    • Casimiro D.R., Wang F., Schleif W.A. et al. Attenuation of simian immunodeficiency virus SIVmac239 infection by prophylactic immunization with dna and recombinant adenoviral vaccine vectors expressing Gag. J Virol 2005; 79:15547-15555.
    • (2005) J Virol , vol.79 , pp. 15547-15555
    • Casimiro, D.R.1    Wang, F.2    Schleif, W.A.3
  • 14
    • 68949110126 scopus 로고    scopus 로고
    • Vaccine-induced, Simian Immunodeficiency Virus-specific CD8+ T cells reduce virus replication but do not protect from Simian Immunodeficiency Virus disease progression
    • Engram J.C., Dunham R.M., Makedonas G. et al. Vaccine-induced, Simian Immunodeficiency Virus-specific CD8+ T cells reduce virus replication but do not protect from Simian Immunodeficiency Virus disease progression. J Immunol 2009; 183:706-717.
    • (2009) J Immunol , vol.183 , pp. 706-717
    • Engram, J.C.1    Dunham, R.M.2    Makedonas, G.3
  • 15
    • 17144465337 scopus 로고    scopus 로고
    • Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239
    • Horton H., Vogel T.U., Carter D.K. et al. Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239. J Virol 2002; 76:7187-7202.
    • (2002) J Virol , vol.76 , pp. 7187-7202
    • Horton, H.1    Vogel, T.U.2    Carter, D.K.3
  • 16
    • 29744438821 scopus 로고    scopus 로고
    • Cytotoxic Tlymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaques
    • McDermott A.B., O'Connor D.H., Fuenger S. et al. Cytotoxic Tlymphocyte escape does not always explain the transient control of simian immunodeficiency virus SIVmac239 viremia in adenovirus-boosted and DNA-primed Mamu-A*01-positive rhesus macaques. J Virol 2005; 79:15556-15566.
    • (2005) J Virol , vol.79 , pp. 15556-15566
    • McDermott, A.B.1    O'Connor, D.H.2    Fuenger, S.3
  • 17
    • 52649177196 scopus 로고    scopus 로고
    • Reduced protection from simian immunodeficiency virus SIVmac251 infection afforded by memory CD8+ T cells induced by vaccination during CD4+ T-cell deficiency
    • Vaccari M., Mattapallil J., Song K. et al. Reduced protection from simian immunodeficiency virus SIVmac251 infection afforded by memory CD8+ T cells induced by vaccination during CD4+ T-cell deficiency. J Virol 2008; 82:9629-9638.
    • (2008) J Virol , vol.82 , pp. 9629-9638
    • Vaccari, M.1    Mattapallil, J.2    Song, K.3
  • 18
    • 69449108369 scopus 로고    scopus 로고
    • Barouch D.H., Liu J., Lynch D.M. et al. Protective Efficacy of a Single Immunization of a Chimeric Adenovirus Vector-Based Vaccine Against SIV Challenge in Rhesus Monkeys. J Virol 2009;
    • Barouch D.H., Liu J., Lynch D.M. et al. Protective Efficacy of a Single Immunization of a Chimeric Adenovirus Vector-Based Vaccine Against SIV Challenge in Rhesus Monkeys. J Virol 2009;
  • 19
    • 55249117992 scopus 로고    scopus 로고
    • Sequential priming with simian immunodeficiency virus (SIV) DNA vaccines, with or without encoded cytokines, and a replicating adenovirus-SIV recombinant followed by protein boosting does not control a pathogenic SIVmac251 mucosal challenge
    • Demberg T., Boyer J.D., Malkevich N. et al. Sequential priming with simian immunodeficiency virus (SIV) DNA vaccines, with or without encoded cytokines, and a replicating adenovirus-SIV recombinant followed by protein boosting does not control a pathogenic SIVmac251 mucosal challenge. J Virol 2008; 82:10911-10921.
    • (2008) J Virol , vol.82 , pp. 10911-10921
    • Demberg, T.1    Boyer, J.D.2    Malkevich, N.3
  • 20
    • 62749156822 scopus 로고    scopus 로고
    • Partial protection of Simian immunodeficiency virus (SIV)-infected rhesus monkeys against superinfection with a heterologous SIV isolate
    • Yeh W.W., Jaru-Ampornpan P., Nevidomskyte D. et al. Partial protection of Simian immunodeficiency virus (SIV)-infected rhesus monkeys against superinfection with a heterologous SIV isolate. J Virol 2009; 83:2686-2696.
    • (2009) J Virol , vol.83 , pp. 2686-2696
    • Yeh, W.W.1    Jaru-Ampornpan, P.2    Nevidomskyte, D.3
  • 21
    • 13844294303 scopus 로고    scopus 로고
    • Kinetics of expansion of SIV Gag-specific CD8+ T lymphocytes following challenge of vaccinated macaques
    • Abdel-Motal U.M., Gillis J., Manson K. et al. Kinetics of expansion of SIV Gag-specific CD8+ T lymphocytes following challenge of vaccinated macaques. Virology 2005; 333:226-238.
    • (2005) Virology , vol.333 , pp. 226-238
    • Abdel-Motal, U.M.1    Gillis, J.2    Manson, K.3
  • 22
    • 34249808840 scopus 로고    scopus 로고
    • Unique pathology in simian immunodeficiency virus-infected rapid progressor macaques is consistent with a pathogenesis distinct from that of classical AIDS
    • Brown C.R., Czapiga M., Kabat J. et al. Unique pathology in simian immunodeficiency virus-infected rapid progressor macaques is consistent with a pathogenesis distinct from that of classical AIDS. J Virol 2007; 81:5594-5606.
    • (2007) J Virol , vol.81 , pp. 5594-5606
    • Brown, C.R.1    Czapiga, M.2    Kabat, J.3
  • 23
    • 33744902339 scopus 로고    scopus 로고
    • Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239
    • Wilson N.A., Reed J., Napoe G.S. et al. Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239. J Virol 2006; 80:5875-5885.
    • (2006) J Virol , vol.80 , pp. 5875-5885
    • Wilson, N.A.1    Reed, J.2    Napoe, G.S.3
  • 24
    • 58149267963 scopus 로고    scopus 로고
    • Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys
    • Liu J., O'Brien K.L., Lynch D.M. et al. Immune control of an SIV challenge by a T-cell-based vaccine in rhesus monkeys. Nature 2009; 457:87-91.
    • (2009) Nature , vol.457 , pp. 87-91
    • Liu, J.1    O'Brien, K.L.2    Lynch, D.M.3
  • 25
    • 61949216736 scopus 로고    scopus 로고
    • Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge
    • Hansen S.G., Vieville C., Whizin N. et al. Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat Med 2009; 15:293-299.
    • (2009) Nat Med , vol.15 , pp. 293-299
    • Hansen, S.G.1    Vieville, C.2    Whizin, N.3
  • 26
    • 67449101823 scopus 로고    scopus 로고
    • Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge
    • Wilson N.A., Keele B.F., Reed J.S. et al. Vaccine-induced cellular responses control simian immunodeficiency virus replication after heterologous challenge. J Virol 2009; 83:6508-6521.
    • (2009) J Virol , vol.83 , pp. 6508-6521
    • Wilson, N.A.1    Keele, B.F.2    Reed, J.S.3
  • 27
    • 34547737913 scopus 로고    scopus 로고
    • Mamu-B*08-positive macaques control simian immunodeficiency virus replication
    • Loffredo J.T., Maxwell J., Qi Y. et al. Mamu-B*08-positive macaques control simian immunodeficiency virus replication. J Virol 2007; 81:8827-8832.
    • (2007) J Virol , vol.81 , pp. 8827-8832
    • Loffredo, J.T.1    Maxwell, J.2    Qi, Y.3
  • 28
    • 43949088824 scopus 로고    scopus 로고
    • Comprehensive immunological evaluation reveals surprisingly few differences between elite controller and progressor Mamu-B*17-positive Simian immunodeficiency virus-infected rhesus macaques
    • Maness N.J., Yant L.J., Chung C. et al. Comprehensive immunological evaluation reveals surprisingly few differences between elite controller and progressor Mamu-B*17-positive Simian immunodeficiency virus-infected rhesus macaques. J Virol 2008; 82:5245-5254.
    • (2008) J Virol , vol.82 , pp. 5245-5254
    • Maness, N.J.1    Yant, L.J.2    Chung, C.3
  • 29
    • 33646461679 scopus 로고    scopus 로고
    • The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication
    • Yant L.J., Friedrich T.C., Johnson R.C. et al. The high-frequency major histocompatibility complex class I allele Mamu-B*17 is associated with control of simian immunodeficiency virus SIVmac239 replication. J Virol 2006; 80:5074-5077.
    • (2006) J Virol , vol.80 , pp. 5074-5077
    • Yant, L.J.1    Friedrich, T.C.2    Johnson, R.C.3
  • 30
    • 6344234923 scopus 로고    scopus 로고
    • Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition
    • Loffredo J.T., Sidney J., Wojewoda C. et al. Identification of seventeen new simian immunodeficiency virus-derived CD8+ T cell epitopes restricted by the high frequency molecule, Mamu-A*02, and potential escape from CTL recognition. J Immunol 2004; 173:5064-5076.
    • (2004) J Immunol , vol.173 , pp. 5064-5076
    • Loffredo, J.T.1    Sidney, J.2    Wojewoda, C.3
  • 31
    • 0037189323 scopus 로고    scopus 로고
    • Diversity considerations in HIV-1 vaccine selection
    • Gaschen B., Taylor J., Yusim K. et al. Diversity considerations in HIV-1 vaccine selection. Science 2002; 296:2354-2360.
    • (2002) Science , vol.296 , pp. 2354-2360
    • Gaschen, B.1    Taylor, J.2    Yusim, K.3
  • 32
    • 56649105122 scopus 로고    scopus 로고
    • Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): A double-blind, randomised, placebo-controlled, test-of-concept trial
    • Buchbinder S.P., Mehrotra D.V., Duerr A. et al. Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. Lancet 2008; 372:1881-1893.
    • (2008) Lancet , vol.372 , pp. 1881-1893
    • Buchbinder, S.P.1    Mehrotra, D.V.2    Duerr, A.3
  • 33
    • 56649114351 scopus 로고    scopus 로고
    • HIV-1 vaccineinduced immunity in the test-of-concept Step Study: A casecohort analysis
    • McElrath M.J., De Rosa S.C., Moodie Z. et al. HIV-1 vaccineinduced immunity in the test-of-concept Step Study: a casecohort analysis. Lancet 2008; 372:1894-1905.
    • (2008) Lancet , vol.372 , pp. 1894-1905
    • McElrath, M.J.1    De Rosa, S.C.2    Moodie, Z.3
  • 34
    • 58149143041 scopus 로고    scopus 로고
    • Reynolds M.R., We i l e r A.M., Weisgrau K.L. et al. Macaques vaccinated with live-attenuated SIV control replication of heterologous virus. J Exp Med 2008; 205:2537-2550.
    • Reynolds M.R., We i l e r A.M., Weisgrau K.L. et al. Macaques vaccinated with live-attenuated SIV control replication of heterologous virus. J Exp Med 2008; 205:2537-2550.
  • 35
    • 67649172577 scopus 로고    scopus 로고
    • Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity
    • Loffredo J.T., Sidney J., Bean A.T. et al. Two MHC class I molecules associated with elite control of immunodeficiency virus replication, Mamu-B*08 and HLA-B*2705, bind peptides with sequence similarity. J Immunol 2009; 182:7763-7775.
    • (2009) J Immunol , vol.182 , pp. 7763-7775
    • Loffredo, J.T.1    Sidney, J.2    Bean, A.T.3
  • 36
    • 0038581912 scopus 로고    scopus 로고
    • The influence of HLA genotype on AIDS
    • Carrington M., and O'Brien S.J. The influence of HLA genotype on AIDS. Annu Rev Med 2003; 54:535-551.
    • (2003) Annu Rev Med , vol.54 , pp. 535-551
    • Carrington, M.1    O'Brien, S.J.2
  • 37
    • 28644451011 scopus 로고    scopus 로고
    • AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis
    • Gao X., Bashirova A., Iversen A.K. et al. AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat Med 2005; 11:1290-1292.
    • (2005) Nat Med , vol.11 , pp. 1290-1292
    • Gao, X.1    Bashirova, A.2    Iversen, A.K.3
  • 38
    • 33750869972 scopus 로고    scopus 로고
    • HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1
    • Altfeld M., Kalife E.T., Qi Y. et al. HLA Alleles Associated with Delayed Progression to AIDS Contribute Strongly to the Initial CD8(+) T Cell Response against HIV-1. PLoS Med 2006; 3:e403.
    • (2006) PLoS Med , vol.3
    • Altfeld, M.1    Kalife, E.T.2    Qi, Y.3
  • 39
    • 0033152036 scopus 로고    scopus 로고
    • New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS
    • Hendel H., Caillat-Zucman S., Lebuanec H. et al. New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J Immunol 1999; 162:6942-6946.
    • (1999) J Immunol , vol.162 , pp. 6942-6946
    • Hendel, H.1    Caillat-Zucman, S.2    Lebuanec, H.3
  • 40
    • 16944366524 scopus 로고    scopus 로고
    • Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS
    • Goulder P.J., Phillips R.E., Colbert R.A. et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat Med 1997; 3:212-217.
    • (1997) Nat Med , vol.3 , pp. 212-217
    • Goulder, P.J.1    Phillips, R.E.2    Colbert, R.A.3
  • 41
    • 0034886611 scopus 로고    scopus 로고
    • Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines
    • Kaslow R.A., Rivers C., Tang J. et al. Polymorphisms in HLA class I genes associated with both favorable prognosis of human immunodeficiency virus (HIV) type 1 infection and positive cytotoxic T-lymphocyte responses to ALVAC-HIV recombinant canarypox vaccines. J Virol 2001; 75:8681-8689.
    • (2001) J Virol , vol.75 , pp. 8681-8689
    • Kaslow, R.A.1    Rivers, C.2    Tang, J.3
  • 42
    • 63949087100 scopus 로고    scopus 로고
    • Adaptation of HIV-1 to human leukocyte antigen class I
    • Kawashima Y., Pfafferott K., Frater J. et al. Adaptation of HIV-1 to human leukocyte antigen class I. Nature 2009; 458:641-645.
    • (2009) Nature , vol.458 , pp. 641-645
    • Kawashima, Y.1    Pfafferott, K.2    Frater, J.3
  • 43
    • 0037013083 scopus 로고    scopus 로고
    • Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57
    • Gillespie G.M., Kaul R., Dong T. et al. Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57. AIDS 2002; 16:961-972.
    • (2002) AIDS , vol.16 , pp. 961-972
    • Gillespie, G.M.1    Kaul, R.2    Dong, T.3
  • 44
    • 0034105485 scopus 로고    scopus 로고
    • HLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the other
    • Goulder P.J., Tang Y., Pelton S.I., and Walker B.D. HLA-B57-restricted cytotoxic T-lymphocyte activity in a single infected subject toward two optimal epitopes, one of which is entirely contained within the other. J Virol 2000; 74:5291-5299.
    • (2000) J Virol , vol.74 , pp. 5291-5299
    • Goulder, P.J.1    Tang, Y.2    Pelton, S.I.3    Walker, B.D.4
  • 45
    • 0034646143 scopus 로고    scopus 로고
    • HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors
    • Migueles S.A., Sabbaghian M.S., Shupert W.L. et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc Natl Acad Sci U S A 2000; 97:2709-2714.
    • (2000) Proc Natl Acad Sci U S A , vol.97 , pp. 2709-2714
    • Migueles, S.A.1    Sabbaghian, M.S.2    Shupert, W.L.3
  • 46
    • 20144389058 scopus 로고    scopus 로고
    • Retroviral recombination in vivo: Viral replication patterns and genetic structure of simian immunodeficiency virus (SIV) populations in rhesus macaques after simultaneous or sequential intravaginal inoculation with SIVmac239Deltavpx/Deltavpr and SIVmac239Deltanef
    • Kim E.Y., Busch M., Abel K. et al. Retroviral recombination in vivo: viral replication patterns and genetic structure of simian immunodeficiency virus (SIV) populations in rhesus macaques after simultaneous or sequential intravaginal inoculation with SIVmac239Deltavpx/Deltavpr and SIVmac239Deltanef. J Virol 2005; 79:4886-4895.
    • (2005) J Virol , vol.79 , pp. 4886-4895
    • Kim, E.Y.1    Busch, M.2    Abel, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.